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Abstract 
Aims: The effects of travel distance and travel time to the primary diabetes care 
provider and waiting time in the practice on health-related quality of life (HRQoL) of 
patients with type 2 diabetes are investigated. 
Research Design and Methods: Survey data of 1313 persons with type 2 diabetes 
from six regions in England (274), Finland (163), Germany (254), Greece (165), the 
Netherlands (354), and Spain (103) were analyzed.  Various multiple linear 
regression analyses with  four different EQ-5D-3L indices (English, German, Dutch 
and Spanish index) as target variables, with  travel distance, travel time, and waiting 
time in the practice as focal predictors and with control for study region, patient’s 
gender, patient’s age, patient’s education, time since diagnosis, thoroughness of 
provider-patient communication were computed. Interactions of regions with the 
remaining five control variables and the three focal predictors were also tested. 
Results: There are no interactions of regions with control variables or focal 
predictors. The indices decrease with increasing travel time to the provider and 
increasing waiting time in the provider’s practice. 
Conclusions: HRQoL of patients with type 2 diabetes might be improved by 
decreasing travel time to the provider and waiting time in the provider’s practice.  
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1 Introduction 
The interaction between diabetes care provider and patient constitutes an essential 
component in diabetes care [1-4]. In this interaction the provider diagnoses the 
patient’s medical condition; discusses with the patient the further course of treatment; 
gives access to drugs and other medical equipment; counsels the patient; and 
supervises the patient’s adherence to the treatment. Without a functioning interaction 
between provider and patient the patient will not fully benefit from the rich medical 
knowledge regarding the treatment of diabetes. Therefore, a functioning interaction 
between provider and patient and, accordingly, appropriate access to the provider 
should be guaranteed. First of all, this access depends upon the insurance status of 
the patient [5-8]. However, even when diabetes treatment is free or at least 
affordable for everybody, access to the providers is not necessarily always the same 
for every patient. It might vary depending on the manner in which the service of the 
provider is delivered. It might depend upon the travel distance and/or travel time to 
the providers’ locations and upon the temporal availability of the providers as 
determined by opening hours and waiting times.  
There are currently few studies addressing location or temporal aspects of service 
delivery on health outcomes. There is some evidence that increasing travel distance 
to the primary diabetes care provider decreases glycemic control [9-11] and 
increases mortality [12]. There are no comparable studies addressing temporal 
aspects of service delivery. There is, however, one empirical evaluation of a program 
for reducing waiting times, i.e. advanced access scheduling [13]. According to this 
evaluation study, applying advanced access scheduling for one year leads to a slight 
improvement of glycemic control in comparison with clinics in which this program has 
not been applied. 
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The above studies provide very valuable insights. However, in seeking to optimize 
diabetes care with regard to needs directly experienced by the patients, it is not 
sufficient to focus solely on glycemic control as a target variable. Instead it is 
necessary to investigate how the different aspects of service delivery affect patients’ 
health-related quality of life (HRQoL). Especially HRQoL in the sense of societal 
evaluations of the patients’ overall health-states, i.e. evaluations which reflect the 
preferences of all members of the society, are of interest. HRQoL in this sense is 
needed as a basis for financial decisions pertaining to the health system. 
Accordingly, HRQoL in this sense is applied to compute Quality Adjusted Life Years 
(QALYs) in cost-utility analyses as they are performed in health-economics [14-15]. 
Hence, knowledge about the impact of aspects of service delivery in diabetes care on 
the patients’ HRQoL in the sense of a societal evaluation would directly provide 
starting points for optimizing diabetes care with regard to the patients’ needs in a 
cost-effective manner. 
Measuring HRQoL in the sense of societal evaluations requires special instruments, 
i.e. preference-based index measurement instruments. Each instrument of this kind 
is based on a multi-attribute classification system for distinguishing health states, 
which is given by the questionnaire. A further component of each preference-based 
index measurement instrument is a scoring function which assigns a societal 
evaluation to each health state distinguished within the classification system. The 
scoring function is given as part of the instructions for evaluating the corresponding 
answers and is determined on the basis of preference judgments given by a person 
sample which should be as representative of the society in question as possible [16]. 
As a prerequisite for computing QALYs scoring functions are always standardized 
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with 1 for full health and 0 for death [14-15]. The resulting value set is often referred 
to as an index [15,17]. 
The best known examples of preference-based index measurement instruments are 
the EQ-5D with its 2 versions EQ-5D-3L and EQ-5D-5L [18-20], the HUI with its 2 
newer versions HUI II and HUI III [21-22], and the SF-6D [23-24]. Hitherto, the 
EQ-5D-3L is the most commonly applied of these instruments. The classification 
system of the EQ 5D 3L is defined by five questions which address ‘Mobility’, ‘Self-
care’, ‘Usual Activities’, ‘Pain/Discomfort’, and ‘Anxiety/Depression’. Three answer 
categories are given for each question.  The first of these categories represents ‘no 
problems at all’; the second ‘moderate problems’; and the third ‘extreme problems’. 
Presently there are 172 official language versions of the EQ-5D-3L [25] and several 
different scoring functions reflecting the preferences in different countries [26].  
The contribution presented here aims at providing information as to how travel 
distance and travel time to the health care provider as well as waiting time at the 
health care provider’s practice influence HRQoL indices based on the EQ-5D-3L. For 
this purpose data which were originally collected in a major European project 
concerned with health provider networks [27] were re-analyzed. In this project, 
surveys of patients with type 2 diabetes were conducted in networks for diabetes 
care from England, Finland, Germany, Greece, the Netherlands and Spain. The EQ-
5D-3L was applied as a component of the survey questionnaire. There is empirical 
evidence that the items of the English, Finnish, German, Dutch, Greek and Spanish 
EQ-5D-3L version function in the same way [28]. As the results provided by the 
analyses presented here apply first of all to the six study countries, the EQ-5D-3L 
indices referring to these countries were used as far as scoring functions for 
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computing such indices were presented in Medline listed papers and as far as these 
functions were empirically meaningful in the sense  theory of measurement [17]. 
These were the indices for England [29], Germany [30], the Netherlands [31] and 
Spain [32]. 
2 Material and Methods 
2.1 Study regions, study participants and study conduction 
One network in each country was investigated: the London Borough of Tower 
Hamlets in England; the region of Keski-Suomi in Finland; the city and rural district of 
Bamberg in Germany; the regional unit of Herakleion on the island of Crete in 
Greece; the region Nieuwe Waterweg Noord en Delft Westland Oostland in the 
Netherlands; and the region of Valencia in Spain. In England seven general 
physician practices associated with the Tower Hamlets Primary Care Trust were 
investigated; in Finland the health centers of eight municipalities within Keski-Suomi; 
in Germany the practices of one general physician and one diabetologist in the city of 
Bamberg, and of two general physicians and one diabetologist in the rural district of 
Bamberg; in Greece, five different institutions providing outpatient care for diabetes; 
in the Netherlands,  five general practitioner health centers; and, in Spain, one 
primary health area. 
The surveys of the diabetes patients were performed with the assistance of the 
diabetes care providers investigated. These providers selected the patients to be 
approached for participation according to criteria defined by the researchers. 
Inclusion criteria for participants were 1) that they were being treated for type 2 
diabetes by the health providers investigated in the project and 2) that they were at 
least 18 years old. The patients were contacted either by post or directly given the 
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questionnaire when visiting their health care provider. The patients who participated 
in the survey completed their questionnaires on their own without any intervention by 
personnel from the service provider or research team. Depending on the most 
feasible method for the particular provider the participants returned their completed 
questionnaires either by mail directly to the local project study centers, or to the care 
provider who then passed them on to the study centers. All surveys were approved 
by national ethics committees with the exception of Bamberg where the approval was 
granted by the ethics committee of the University Medical Center of Erlangen and 
with the exception of Herakleion where approval was granted by the relevant 
committee of the hospital. Data were collected between October 2011 and March 
2012. 
2.2 Study variables 
The questionnaire used for the surveys contained various items addressing socio-
demographic features, health, health-related behavior and health treatment. 
However, only selected elements of these items were applied in the analyses 
presented here. These will be described in the subsections below. 
2.2.1 Exclusion criteria 
The questionnaire contained two questions addressing the participant’s competence 
in mastering the questionnaire language. These questions were used to identify 
those responders who had insufficient mastery of the questionnaire language and 
were thus excluded from the analyses. 
2.2.2 Basic medical characteristics 
The questionnaire also contained questions regarding the participants’ weight, 
height, HbA1c value, systolic blood pressure and cholesterol level.  
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2.2.3 Control variables 
Some of the questionnaire items referred to variables which had to be controlled in 
the analyses because they can be expected to influence health states and, by way of 
this, HRQoL. These were age, gender, educational attainment, the year when the 
patient’s diabetes was diagnosed, and the thoroughness with which the provider 
communicated with the patient. Educational attainment was assessed by asking 
participants whether they had left school after the minimum school leaving age of 
their country. Those answering ‘yes’ were classified as having a lower level of 
educational attainment than those who answered ‘no’. The year of their diagnosis 
was used to compute the duration of the diagnosed diabetes at the time of the 
survey. The question concerned with the provider-patient communication was ’How 
often does your main diabetes health care provider discuss with you your diabetes 
related problems so thoroughly that you do not have any further questions?’.  The 
answer modality was a five category scale with the two extreme categories labeled 
’Never’ or ’Always’ respectively. 
2.2.4 Focal predictors 
The questionnaire contained three questions regarding the three variables which are 
investigated as focal predictors: travel distance; travel time; and waiting time in the 
practice. The questions about travel distance and travel time referred to the travel 
from the place from which the patient usually set off to visit the provider to the 
provider’s place. Except for the English patients (who were asked to report in miles), 
travel distance was assessed in kilometers. Travel and waiting time were assessed in 
minutes.  
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2.2.5 Target variables 
The questionnaire also contained the EQ-5D-3L questionnaire on which the target 
variables, i.e. the indices of HRQoL, are based (see above).  
2.3 Study participants included in analyses 
Study participants returning a questionnaire were excluded from the analyses when 
they did not have sufficient mastery of the questionnaire language and also when 
there were too few data supplied by a participant, i.e. when data for more than two of 
the five control variables, more than one of the three focal predictors, or more than 
two of the five EQ-5D-3L items were missing. 
2.4 Statistical analyses 
Descriptive statistics were computed for exclusion criteria, basic medical 
characteristics, control variables, focal predictors, and target variables. Percentages 
were computed for dichotomous variables; means, standard deviations, and minima 
and maxima for continuous variables. This was undertaken for both the total sample 
and separately for the six region-specific samples. Region differences regarding 
dichotomous variables were statistically tested using chi-square tests, and region 
differences regarding continuous variables using multiple linear regressions with 
dummy coded regions as the predictor variable. To cope with skewed distributions 
within the different regions, region differences regarding continuous variables were 
also tested using Kruskal-Wallis tests. 
Missing data for control variables, the focal predictors and EQ-5D-3L items were 
handled with two alternative approaches: (1) only participants without missing data 
were included in the analyses; and (2) missing data were imputed using multiple 
imputations [33]. The imputation of each of these variables was based upon a model 
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with the remaining of these variables and dummy coded regions as predictors. Age, 
time since diagnosis, thoroughness of communication and all focal predictors were 
handled as metric variables and constrained to the range of values defined by the 
valid data. The five EQ-5D-3L items were handled as ordinal variables with a limited 
set of categories. Gender, education and dummy coded region were handled as 
nominal variables. To limit the impact of the stochastic part in the imputation on the 
resulting statistics, 1000 different data sets with imputed values were produced. The 
four different EQ-5D-3L indices were computed on the basis of the resulting data 
sets.  
Two alternative approaches were applied to control for the influence of the regions 
and the control variables: (1) the original value approach and (2) the residual value 
approach. In the original value approach the four different EQ-5D-3L indices were 
regressed via multiple linear regression models on dummy coded regions, control 
variables, and focal predictors. In the residual value approach the focal predictors 
and the EQ-5D-3L indices were first regressed on dummy coded regions and control 
variables and, subsequently, the unstandardized residuals for the EQ-5D-3L indices 
were regressed on the unstandardized residuals for the focal predictors.  
All analyses were performed for the total sample. To test for region-specific 
differences between the regression coefficients, further regression models containing 
interaction terms with dummy coded countries were computed. In the original value 
approach the interactions of dummy coded countries with the control variables and 
the focal predictors were included; in the residual value approach these were the 
interactions with the residuals of the focal predictors. A statistically significant 
increase in the proportion of variance explained by the model with interaction terms 
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in comparison with the corresponding model without interaction terms was taken as 
evidence for region specific differences between the regression coefficients. In this 
case further regression models were computed each of which only contained the 
interactions of dummy coded country with one of the variables in question.  A 
statistically significant increase in the proportion of variance in comparison with the 
corresponding model without interaction terms was taken as evidence for region 
specific differences between the regression coefficients for that variable for which the 
interaction terms had been included.  
When the regression analyses were performed with imputed data, the 
unstandardized regression coefficients were determined by aggregating the 
corresponding estimates from the multiple data sets using the rules proposed by 
Rubin [33]. The corresponding standard errors, which were used for inference 
statistical testing of the unstandardized regression coefficients, were also determined 
according to the aggregation rules of Rubin. The standardized regression coefficients 
were computed by first estimating standard deviations for the predictor and the 
criterion variables from all 1000 data records resulting from the multiple imputations 
together and then using these standard deviations for deriving the standardized 
regression coefficients from the unstandardized coefficients. The unadjusted multiple 
R2 (i.e. the estimates for the proportion of variance explained by the respective 
model), were determined by computing the model for all 1000 data sets together. For 
computing adjusted multiple R2 and for performing statistical inference tests referring 
to multiple R2s the sample size of one single data set was presupposed. 
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3 Results 
More than 6000 questionnaires were distributed of which 1638 were returned and 
1313 met the inclusion criteria (see Table 1). The proportion of excluded 
questionnaires is largest in England (42.3%) which is due to the fact that about 40% 
of all respondents in this sample were of Bangladeshi ethnicity who, due to lower 
levels of stated proficiency in the English language, did not meet the inclusion criteria 
for this analysis. Altogether, 21.0% of the distributed questionnaires were included in 
the final analyses when missing data were imputed and these proportions vary from 
8.2% for England to 55.0% for Germany (see Table 1). Basic medical variables are 
distributed as can be expected for samples of type 2 diabetes patients (see Table 1). 
******************** 
Insert table 1 about here 
******************** 
In the sample of study participants included, 2.9% of the data for the investigated 
variables are missing. Within the control variables and focal predictors the 
percentages of missing data range from 0.6% for age to 11.3% for time since 
diagnosis (see Table 2).  For the EQ-5D-3L items the percentages of missing values 
are 0.5% (4/1313) for mobility, 0.7% (9/1313) for self-care, 0.4% (5/1313) for usual 
activities, 0.8% (10/1313) for pain/discomfort, and 1.8% (23/1313) for 
anxiety/depression. There are 935 participants with data for all variables considered 
in the main analyses (see Table 1). The six study regions differ with regard to all 
investigated variables except for gender (see Table 2).   
17 
 
******************** 
Insert table 2 about here 
******************** 
In only one of 16 investigated cases (i.e.: missing data imputed; original value 
approach; Dutch index) the model with all interaction terms explained significantly 
more variance than the model without any interaction terms. However, in this case 
none of the models with interaction terms for only one predictor variables explains 
significantly more variance than the model without any interaction terms. Hence, in 
none of the 16 analyses the regression coefficients differ essentially between the 
countries. The original value approach and the residual value approach render 
virtually the same regression coefficients for the focal predictors when applied to the 
same data set and the same index. Therefore, only the regression coefficients 
determined with the residual value approach for the total sample are presented here 
(see Table 3).   
******************************** 
Insert Table 3 about here 
******************************* 
When only the complete data sets are considered the three focal predictors always 
explain a larger proportion of variance than in the case when data with missing 
values imputed are considered (see Table 3). Except for this difference the analyses 
of both data sets provide very similar results. The travel distance to the provider has 
no impact on HRQoL independently of which index is applied, whereas all indices 
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decrease in a statistically significant manner with increasing waiting time in practice 
(see Table 3). For travel time to the provider the results are less distinct. When only 
the complete data sets are considered then travel time has a statistically significant 
effect on all four indices of HRQoL. HRQoL decreases with increasing travel time 
(see Table 3). The same tendency shows for the data set with missing values 
imputed. However, for the German and the Spanish index this tendency is no longer 
statistically significant (see Table 3). 
4 Discussion 
The study presented here has been performed with six person samples which stem 
from six different regions. These samples are very different (see Table 2). . 
Relationships determined on the basis of such heterogeneous data can be expected 
to be well generalizable. The fact that there are no interactions between the regions 
and the other variables is further evidence for the generalizability of the results. 
However, the sample sizes for the individual regions are not very large and with 
larger sample sizes some of the interactions might become statistically significant. 
Yet, as no interaction effect was detected with the given sample sizes, interaction 
effects detected with larger sample sizes are unlikely to be very strong.  
The study is merely correlational, i.e. all variables have been assessed at the same 
time without a voluntary manipulation of the focal predictors. Consequently, the data 
do not tell us whether the statistical significant relationships between two of the focal 
predictors and the indices are actually causal with the focal predictors being the 
cause. This can only be assumed based on plausibility. This assumption, however, is 
trustworthy enough to substantiate pilot interventions in which the hypothesized 
cause variable is manipulated to affect the hypothesized cause.  If such an 
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intervention is evaluated with a randomized controlled trial this will give clearer 
information about causality. 
Travel distance, travel time and waiting time have been determined by asking the 
study participants. Accordingly, these variables are less reliable than physical 
measurements. However, as long as the participants’ estimations vary by chance 
with the true values as means, the statistics obtained from a large sample of 
participants will be quite accurate.  
Missing values were treated in two different manners: (1) only complete data sets and 
(2) data sets with missing data imputed were analysed. Moreover, two different 
approaches, i.e. (1) original value approach and (2) residual value approach, were 
applied for statistical analyses. The latter two approaches provided virtually the same 
results. This enhances trustworthiness of the results. However, when only complete 
data were analyzed the proportions of explained variance were always higher than 
when data with missing values imputed were analysed. There are at least two 
possible explanations for this difference: (1) the approach applied for imputing 
missing data creates more disturbances in the data than adequate; and (2) the data 
provided by people who have skipped some questions have a lower quality than 
those of people who answered all questions. Both explanations imply that if both 
approaches provide different results regarding the regression coefficients the results 
of the analyses with only complete data sets are more likely to be true. 
EQ-5D-3L indices decrease significantly with travel time to the provider, whereas 
travel distance has no statistically significant effect. These results contain important 
new information. In previous studies, only travel distance but not travel time was 
considered [9-12]. The results which emerge when both variables are investigated 
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together suggest that the previous findings are not caused by the distance itself but 
by the travel time (which is usually correlated with distance). This, in turn, means that 
the negative effect of travel distance can, to a certain extent, be compensated by a 
good road and a good public transport system.  
The results regarding waiting time in the practice also provide new information. 
Hitherto there was only very weak empirical evidence that temporal availability of the 
provider has an effect on patients’ health [13]. The results presented here 
corroborate this effect. In addition to this they show that this effect not only pertains 
to glycemic control, but also to health as it is perceived by the patients themselves. 
There are at least two possible explanations for the relationship between waiting time 
and EQ-5D-3L indices. One explanation is that waiting time is an indicator of 
overload of the provider and that this overload leads to poorer care delivered by the 
provider. The other explanation is that longer waiting time detains the patients from 
visiting the provider on occasions when they should do, and that these limitations on 
their visits lead to reduced care. The first explanation can, by and large, be ruled out 
because the thoroughness of provider-patient communication has also been included 
in the regression analyses and because this variable would also indicate overload. 
So, it is very probable that the second explanation is true. If this is actually so then 
modifications of the waiting time in the practices will have a direct impact on the 
health as perceived by the patients. 
The unstandardized regression coefficients referring to travel time and waiting time 
are quite small. However, the target variables, i.e. the EQ-5D-3L indices, are 
represented by a very small interval of numbers. The complete range of health states 
between death and full health is mapped onto the interval between zero and one. 
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Moreover, travel time and waiting time are measured in minutes, i.e. the 
unstandardized regression coefficients represent the decrease of EQ-5D-3L indices 
caused by one single additional minute for travel time or waiting time. The decrease 
caused by ten additional minutes is ten times as large. Note further that the 
conception of a minimal clinically relevant difference does not apply to indices of 
HRQoL. From the perspective of health economics, the only relevant question is 
whether the difference is worth the money it costs. The effects of several cost-
effective interventions with small effects can add up to a cost-effective large effect. 
Accordingly, also interventions with very small effects should be undertaken when 
they do not cost too much.  
If the relationships found in the analyses are actually causal with HRQoL being the 
effect and the focal predictors being the causes, then these results indicate that the 
HRQoL of diabetes patients can be improved by reducing travel time to the providers 
and waiting time in the providers’ practices. This should be tested by implementing 
interventions in which travel time and/or waiting time in the provider practice is 
reduced and by evaluating whether these interventions actually increase HRQoL. If 
the interventions show to be successful applying these interventions in routine 
practice would bring a lot of benefits for the patients.   
The first step to designing the interventions just outlined is looking for measures by 
means of which travel and waiting times can be reduced. For travel time there are 
two main approaches. The first is distributing diabetes care in such a way over the 
regions that all inhabitants of these regions can reach diabetes care with the existing 
road and public transport system in as short a time as possible. This can be done 
either by distributing those persons who presently perform the diabetes care over the 
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regions or by delegating diabetes care from more central providers to providers who 
are closer to the patients. The second approach is improving the existing road and 
public transport system. However, in many countries both approaches already apply 
to the fullest extent practicable. Hence, there do not seem to be many chances to 
improve HRQoL of diabetes patients in a cost-effective manner by intensifying efforts 
along these lines. By contrast, there might be more potential still to reduce waiting 
times in practices by better organization of the appointments system and the 
organization of work in the practices. Taking this route might lead to very cost-
effective improvements of HRQoL in diabetes patients.   
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Table 1: General information about the sample 
 Total 
sample 
English 
region 
Finnish 
region 
German 
region 
Greek 
region 
Dutch 
region 
Spanish 
region 
Statistics determining the study samplea 
Questionnaires 
distributed 
6245 3343 436 462 600 779 625 
Questionnaires 
returned 
1638 
(26.2%) 
475 
(14.2%) 
183 
(42.0%) 
286 
(61.9%) 
179 
(29.8%) 
400 
(51.3%) 
115 
(18.4%) 
Sufficient 
language 
competence 
1459 
(23.4%) 
313  
(9.4%) 
183 
(42.0%) 
282 
(61.0%) 
179 
(29.8%) 
387 
(49.7%) 
115 
(18.4%) 
Sufficient datab 1458 
(23.3%) 
404 
(12.1%) 
163 
(37.4%) 
258 
(55.8%) 
165 
(27.5%) 
365 
(46.9%) 
103 
(16.5%) 
Participants 
included 
1313 
(21.0%) 
274  
(8.2%) 
163 
(37.4%) 
254 
(55.0%) 
165 
(27.5%) 
354 
(45.4%) 
103 
(16.5%) 
Participants 
with complete 
datac  
935 
(15.0%) 
177 
(5.3%) 
118 
(27.1%) 
192 
(41.6%) 
129 
(21.5%) 
257 
(33.0%) 
62 
(9.9%) 
Medical characteristics of the study sample 
BMI        
Valid datad 1321 248 174 264 166 368 101 
Mean 30.0 29.8  30.7 31.9 29.7 28.9 28.9 
Standard 
deviation 
5.8 6.8 5.9 6.2 4.6 5.0 5.0 
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HbA1c % 
(mmol/mol) 
       
Valid datad 726 79 94 197 119 189 48 
Mean 6.5 (48) 6.6 (49) 6.4 (46) 6.9 (52) 6.0 (42) 6.4 (47) 6.7 (50) 
Standard 
deviation 
1.4 (15) 1.2 (13) 1.1 (12) 1.1 (12) 2.2 (24) 1.1 (13) 1.5 (17) 
Systolic blood 
pressure 
       
Valid datad 975 112 160 230 144 243 86 
Mean 135.0 127.1  135.5 135.4 132.9 138.5 136.5 
Standard 
deviation 
16.4 19.5 13.5 15.9 14.7 17.3 15.1 
Cholesterol 
mmol/L 
(mg/dL) 
       
Valid datad 552 97 80 109 116 102 48 
Mean 4.8 
(185) 
4.2 
(164) 
4.7 
(180) 
5.0 
(192) 
4.8 
(186) 
5.1 
(198) 
4.9 (189) 
Standard 
deviation 
1.5 (56) 1.4 (53) 1.3 (51) 1.3 (49) 1.4 (52) 1.8 (71) 1.4 (53) 
a Percentages refer to questionnaires distributed.  
b Participants with data for at least three of the five control variables, at least two of 
the three focal predictors, and at least three of the five EQ-5D-3L items.  
c Data for all control variables, focal predictors and EQ-5D-3L items. 
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d  Valid data vary due to missing values.  
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Table 2: Distributions of the investigated variablesa 
 Total 
sample 
English 
region 
Finnish 
region 
German 
region 
Greek 
region 
Dutch 
region 
Spanish 
region 
Region 
differences 
Control variables 
Gender 
Valid 
data 
1290 269 159 253 165 343 101  
Male 
gender 
57.2% 
(738) 
59.9% 
(161) 
62.9% 
(100) 
51.4% 
(130) 
57.0% 
(94) 
57.1% 
(196) 
56.4% 
(57) 
Not 
significantb 
Age in years 
Valid 
data 
1305 272 161 254 165 351 102  
Mean 
(SD) 
65.4 
(11.1) 
63.6 
(12.6) 
63.7 
(9.5) 
65.9 
(11.1) 
66.1 
(10.5) 
66.1 
(10.2) 
68.6 
(11.6) 
p<0.001c,d 
Education 
Valid 
data 
1243 249 151 246 160 342 95  
High 
education 
54.3% 
(675) 
38.2 
(95) 
58.3% 
(88) 
65.4% 
(161) 
26.9% 
(43) 
75.1% 
(257) 
32.6% 
(31) 
p<0.001b 
Time since diagnosis in years 
Valid 
data 
1164 243 157 225 145 311 83  
Mean 
(SD) 
10.5 
(8.9) 
9.7 
(8.3) 
9.7 
(8.0) 
12.0 
(10.4) 
10.8 
(8.6) 
9.1 
(7.0) 
14.9 
(12.0) 
p<0.001c,d 
Thoroughness of communicatione 
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Valid 
data 
1262 268 152 241 163 342 96  
Mean 
(SD) 
4.1 
(1.2) 
3.9 
(1.3) 
4.2 
(1.0) 
4.2 (1.1) 3.9 
(1.3) 
4.4 
(1.0) 
3.4 (1.5) p<0.001c,d 
Focal predictors 
Travel distance to provider in kilometres 
Valid 
data 
1253 246 158 251 161 344 93  
Mean 
(SD) 
5.2 
(10.3) 
1.6 
(2.8) 
8.8 
(10.2) 
5.5 (6.1) 15.6 
(20.5) 
2.1 
(5.6) 
1.4 (1.3) p<0.001c,d 
Travel time to provider in minutes 
Valid 
data 
1276 263 162 246 164 344 97  
Mean 
(SD) 
14.8 
(14.3) 
14.8 
(10.4) 
16.3 
(11.3) 
13.3 
(9.6) 
29.2 
(25.6) 
8.6 
(8.4) 
13.7 
(9.6) 
p<0.001c,d 
Waiting time in practice in minutes 
Valid 
data 
1274 267 154 251 163 340 99  
Mean 
(SD) 
27.6 
(30.4) 
18.9 
(14.6) 
13.4 
(10.4) 
42.8 
(32.0) 
55.0 
(44.8) 
13.0 
(18.8) 
39.0 
(28.8) 
p<0.001c,d 
Target variables 
Valid 
data 
1265 265 160 242 159 341 98  
EQ-5D-3L index for England 
Mean 0.77 0.70 0.81 0.77 0.69 0.85 0.75 p<0.001c,d 
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(SD) (0.21) (0.26) (0.17) (0.19) (0.20) (0.16) (0.22) 
EQ-5D-3L index for Germany 
Mean 
(SD) 
0.87 
(0.14) 
0.83 
(0.17) 
0.88 
(0.11) 
0.86; 
(0.13) 
0.85; 
(0.14) 
0.91 
(0.11) 
0.85 
(0.15) 
p<0.001c,d 
EQ-5D-3L index for the Netherlands 
Mean 
(SD) 
0.80 
(0.19) 
0.74 
(0.23) 
0.85 
(0.15) 
0.80 
(0.18) 
0.69; 
(0.19) 
0.88 
(0.14) 
0.78 
(0.19) 
p<0.001c,d 
EQ-5D-3L for Spain 
Mean 
(SD) 
0.81 
(0.20) 
0.74 
(0.24) 
0.84 
(0.15) 
0.82 
(0.18) 
0.75 
(0.19) 
0.88 
(0.14) 
0.79 
(0.22) 
p<0.001c,d 
a  Valid data vary due to missing values.  
b Pearson’s chi-square test. 
c Multiple linear regression with ‘region’ as dummy coded predictor variable. 
d Kruskal-Wallis test. 
e Coded from 1 for ‘never’ to 5 for ‘always’. 
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Table 3: Impact of focal predictors on EQ-5D-3L indicesa 
 English index German index Dutch index Spanish 
index 
Analyses with complete data (n=935) 
Travel distance to 
provider (km) 
0.0009 
(0.044) 
0.0003 
(0.020) 
0.0011 
(0.060) 
0.0007 
(0.038) 
Travel time to 
provider (min) 
-0.0015 (-
0.107)* 
-0.0008 (-
0.084)* 
-0.0015 (-
0.118)** 
-0.0014 (-
0.109)* 
Waiting time in 
practice (min) 
-0.0009 (-
0.117)*** 
-0.0006 (-
0.115)*** 
-0.0008 (-
0.116)*** 
-0.0007 (-
0.095)** 
Adjusted multiple R2 0.020*** 0.018*** 0.021*** 0.016*** 
Analyses with missing data imputed (n=1313) 
Travel distance to 
provider (km) 
0.0004 
(0.018) 
0.0000 
(0.001) 
0.0005 
(0.028) 
0.0001 
(0.007) 
Travel time to 
provider (min) 
-0.0011 (-
0.072)* 
-0.0006 (-
0.064) 
-0.0010 (-
0.076)* 
-0.0009 (-0-
067) 
Waiting time in 
practice (min) 
-0.0008 (-
0.105)*** 
-0.0005 (-
0.099)*** 
-0.0007 (-
0.110)*** 
-0.0006 (-
0.083)** 
Adjusted multiple R2 0.014*** 0.012*** 0.015*** 0.009*** 
aAll variables are unstandardized residuals from multiple linear regressions with 
dummy coded country, gender, age, education, time since diagnoses and 
thoroughness of communication as predictors. Except in rows for adjusted multiple 
R2 the first number in the cell is the unstandardized and the number in brackets the 
standardized regression coefficient. Significance levels are * = p<0.05; ** = p<0.01; 
and *** = p<0.001. 
